Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons
Ritchie, Louise and Tate, Rothwelle and Chamberlain, Luke H. and Robertson, Graham and Zagnoni, Michele and Sposito, Teresa and Wray, Selina and Wright, John A. and Bryant, Clare E. and Gay, Nicholas J. and Bushell, Trevor J. (2018) Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons. Neuropharmacology, 135. pp. 1-10. ISSN 0028-3908 (https://doi.org/10.1016/j.neuropharm.2018.02.025)
Preview |
Text.
Filename: Ritchie_etal_Neuropharmacology2018_Toll_like_receptor_3_activation_impairs_excitability_and_synaptic.pdf
Accepted Author Manuscript License: Download (2MB)| Preview |
Abstract
Toll like receptor 3 (TLR3) belongs to a family of pattern recognition receptors that recognise molecules found on pathogens referred to as pathogen associated molecular patterns (PAMPs). Its involvement in innate immunity is well known but despite its presence in the central nervous system (CNS), our knowledge of its function is limited. Here, we have investigated whether TLR3 activation modulates synaptic activity in primary hippocampal cultures and induced pluripotent stem cell (iPSC)-derived neurons. Synaptically driven spontaneous action potential (AP) firing was significantly reduced by the TLR3 specific activator, poly I:C, in a concentration-dependent manner following both short (5 min) and long exposures (1h) in rat hippocampal cultures. Notably, the consequence of TLR3 activation on neuronal function was reproduced in iPSC-derived cortical neurons, with poly I:C (25µg/ml, 1h) significantly inhibiting sAP firing. We examined the mechanisms underlying these effects, with poly I:C significantly reducing peak sodium current, an effect dependent on the MyD88-independent TRIF dependent pathway. Furthermore, poly I:C (25µg/ml, 1h) resulted in a significant reduction in miniature excitatory postsynaptic potential (mEPSC) frequency and amplitude and significantly reduced surface AMPAR expression. These novel findings reveal that TLR3 activation inhibits neuronal excitability and synaptic activity through multiple mechanisms, with this being observed in both rat and human iPSC-derived neurons. These data might provide further insight into how TLR3 activation may contribute to neurodevelopmental disorders following maternal infection and in patients with increased susceptibility to herpes simplex encephalitis.
ORCID iDs
Ritchie, Louise ORCID: https://orcid.org/0000-0002-1315-4098, Tate, Rothwelle, Chamberlain, Luke H. ORCID: https://orcid.org/0000-0002-8701-4995, Robertson, Graham ORCID: https://orcid.org/0000-0002-3841-874X, Zagnoni, Michele ORCID: https://orcid.org/0000-0003-3198-9491, Sposito, Teresa, Wray, Selina, Wright, John A., Bryant, Clare E., Gay, Nicholas J. and Bushell, Trevor J. ORCID: https://orcid.org/0000-0003-4145-9670;-
-
Item type: Article ID code: 63383 Dates: DateEvent30 June 2018Published2 March 2018Published Online23 February 2018AcceptedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Faculty of Engineering > Electronic and Electrical Engineering
Technology and Innovation Centre > Advanced Science and Technology
Technology and Innovation Centre > BionanotechnologyDepositing user: Pure Administrator Date deposited: 27 Feb 2018 10:26 Last modified: 12 Nov 2024 03:56 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/63383